Literature DB >> 19424747

Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis.

Robert W O'Rourke1.   

Abstract

Obesity is a major health crisis, and diabetes is one of its most serious sequelae. Obesity is associated with a state of chronic systemic inflammation that is a primary etiologic factor in the development of insulin resistance and diabetes. This inflammatory state is based in adipose tissue and mediated in large part by tissue macrophages and their cytokine and adipokine products. Recent research has identified specific molecular mediators of the link between inflammation and insulin resistance in obesity. Study of these mediators and the specific mechanisms underlying inflammation and insulin resistance in obesity holds the promise for novel pharmacotherapy for obesity-related metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424747     DOI: 10.1007/s00268-009-0067-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  75 in total

1.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity.

Authors:  Carey N Lumeng; Stephanie M Deyoung; Jennifer L Bodzin; Alan R Saltiel
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

3.  Alterations in peripheral blood lymphocyte cytokine expression in obesity.

Authors:  R W O'Rourke; T Kay; E A Lyle; S A Traxler; C W Deveney; B A Jobe; C T Roberts; D Marks; J T Rosenbaum
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.

Authors:  N Paquot; M J Castillo; P J Lefèbvre; A J Scheen
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

7.  Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

Authors:  J Nilsson; S Jovinge; A Niemann; R Reneland; H Lithell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

8.  Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity.

Authors:  Fredrik Karpe; Barbara A Fielding; Vera Ilic; Ian A Macdonald; Lucinda K M Summers; Keith N Frayn
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases.

Authors:  Federico Licastro; Giuseppina Candore; Domenico Lio; Elisa Porcellini; Giuseppina Colonna-Romano; Claudio Franceschi; Calogero Caruso
Journal:  Immun Ageing       Date:  2005-05-18       Impact factor: 6.400

View more
  7 in total

1.  Risk factors for acute kidney injury after orthotopic liver transplantation: A single-center data analysis.

Authors:  Zhi-Qiang Zhou; Long-Chang Fan; Xu Zhao; Wei Xia; Ai-Lin Luo; Yu-Ke Tian; Xue-Ren Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 2.  Fracture healing under healthy and inflammatory conditions.

Authors:  Lutz Claes; Stefan Recknagel; Anita Ignatius
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

3.  Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.

Authors:  Christos G Galanakis; Markos Daskalakis; Andreas Manios; Argyro Xyda; Apostolos H Karantanas; John Melissas
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery.

Authors:  Georgios Marantos; Markos Daskalakis; Nikolaos Karkavitsas; Ioannis Matalliotakis; John A Papadakis; John Melissas
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

Review 5.  Metabolically Healthy Obesity and Bariatric Surgery.

Authors:  Adriana Florinela Cătoi; Luca Busetto
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

6.  Mediators of inflammation in obesity and its comorbidities.

Authors:  Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2010-09-21       Impact factor: 4.711

Review 7.  Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.

Authors:  Franco Cavaleri
Journal:  Int J Inflam       Date:  2018-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.